CLASS II Drug recall · Reported 25 Sep 2013 · FDA Enforcement Report
Bevacizumab 1.25 mg/ PF, Avella Specialty Pharmacy, Phoenix recalled
Avella of Deer Valley is recalling Bevacizumab 1.25 mg/ PF, Avella Specialty Pharmacy, Phoenix, AZ, 85085, 877-782-7684, distributed nationwide in the US. The recall was initiated on 9 Sep 2013 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1058-2013
- FDA event ID
- 66210
- Recalling firm
- Avella of Deer Valley, Phoenix, AZ
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 9 Sep 2013
- FDA classified
- 16 Sep 2013
- Reported
- 25 Sep 2013
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Sterility
Timeline
| 9 Sep 2013 | Recall initiated by company | |
| 16 Sep 2013 | Classified by FDA | +7 days |
| 25 Sep 2013 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Bevacizumab 1.25 mg/0.05 mL PF, Avella Specialty Pharmacy, Phoenix, AZ, 85085, 877-782-7684
Where it was distributed
Nationwide and Puerto Rico
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.
Which lots are affected?
12-20130508@179, Exp 11/3/2013
Where was it sold?
Nationwide and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 66210This product is part of a recall event; the main page for the event is Vancomycin PF (BSS) 1%, Avella Specialty Pharmacy, Phoenix recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Vancomycin PF (BSS) 1%, Avella Specialty Pharmacy, Phoenix recalled | Avella of Deer Valley | Sterility | Nationwide |
More recalls from Avella of Deer Valley
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Hydroxyprogesterone Caproate 250 MG/ML (in Sesame Oil) recalled | Avella of Deer Valley | Other | Nationwide |
| Drug | CLASS II | Vancomycin PF (BSS) 1%, Avella Specialty Pharmacy, Phoenix recalled | Avella of Deer Valley | Sterility | Nationwide |
Other Bevacizumab recalls
All 16| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bevacizumab 1.75 mg/ - syringe, Intravitreal Total Volume recalled | RC Outsourcing | Sterility | Nationwide |
| Drug | CLASS II | Bevacizumab 1.25 MG/ Solution for Injection syringes recalled | Pine Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS III | Bevacizumab 2.5 mg/, Solution for Injection recalled | Pine Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Bevacizumab, 1.25 mg/ MJ Syringe Intravitreal Injection recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled | Pacifico National | Sterility | PR |